Keywords: Sigma-Tau, Anti-malarial, Eurartesim, Research

Positive clinical trials on new anti-malarial developed by Sigma-Tau

Article | 28 September 2009

Print This

Results from Phase III clinical trials conducted on over 2,500 patients in Africa and Asia, of whom 1,600 were children aged under ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in